Prudential Financial
AQST icon

Prudential Financial’s Aquestive Therapeutics AQST Stock Holding History

Prudential Financial’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.7K Buy
19,395
+1,690
+10% +$7.11K ﹤0.01% 2367
2026
Q1 		$73.5K Buy
+17,705
New +$71.9K ﹤0.01% 2267
2024
Q4 		– Sell
-14,475
Closed -$72.1K – 2294
2024
Q3 		$72.1K Buy
+14,475
New +$56.3K ﹤0.01% 2610
2024
Q2 		– Sell
-20,200
Closed -$86.1K – 2693
2024
Q1 		$86.1K Sell
20,200
-4,800
-19% -$16K ﹤0.01% 2539
2023
Q4 		$50.5K Hold
25,000
– – ﹤0.01% 2549
2023
Q3 		$38.3K Buy
25,000
+2,600
+12% +$4.47K ﹤0.01% 2527
2023
Q2 		$37K Buy
+22,400
New +$40.5K ﹤0.01% 2563

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Prudential Financial's AQST Position: Q2 2026 in Review

Prudential Financial increased its Aquestive Therapeutics (AQST) stake by 9.5% in Q2 2026, buying an estimated $7.11K and bringing the position to 19,395 shares worth $80.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2367.

Prudential Financial first reported a position in AQST in Q2 2023 and has held it in 7 quarters since. The position peaked at $86.1K in Q1 2024. 185 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Prudential Financial held 19,395 shares of Aquestive Therapeutics worth $80.7K as of Q2 2026.
  • Prudential Financial bought 1,690 Aquestive Therapeutics shares in Q2 2026, an estimated $7.11K.
  • Aquestive Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2367 holding.
  • Prudential Financial first reported a position in Aquestive Therapeutics in Q2 2023 and has held it in 7 quarters since.
  • Prudential Financial's Aquestive Therapeutics position peaked at $86.1K in Q1 2024.
  • 185 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.